(Q35636708)
Statements
1 reference
Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis (English)
1 reference
D van der Heijde
1 reference
A Boonen
1 reference
J L Severens
1 reference
A Boendermaker
1 reference
R Landewé
1 reference
J Braun
1 reference
J Brandt
1 reference
J Sieper
1 reference
Sj van der Linden
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference